• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Bukwang Pharma subsidiary raises 3 billion won biospectrumasia
    July 15, 2019
    Contera Pharma, a Danish subsidiary of South Korea based Bukwang Pharmaceutical, has attracted 3 billion won in Series A from Medici Investments. Conterapa expects JM-010, which is underway in Europe, to accelerate its Phase 2 clinical trials.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service